Barclays Adjusts Dr. Reddy's Laboratories' Price Target to $69 From $68, Maintains Overweight Rating
Barclays Adjusts Dr. Reddy's Laboratories' Price Target to $69 From $68, Maintains Overweight Rating
巴克萊將雷迪博士實驗室的目標股價從68美元調整至69美元，維持增持評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間